Search Results - "Cooper, Joanna A."

Interferon β-1a for early multiple sclerosis: CHAMPS trial subgroup analyses by Beck, Roy W., Chandler, Danielle L., Cole, Stephen R., Simon, Jack H., Jacobs, Lawrence D., Kinkel, R. Philip, Selhorst, John B., Rose, John W., Cooper, Joanna A., Rice, George, Murray, Thomas J., Sandrock, Alfred W.

“…The objective of this work was to assess the effect of interferon β‐1a (Avonex®) on the rate of development of clinically definite multiple sclerosis and brain…”
Get full text

Response of intrathecal baclofen resistance to dose reduction by COOPER, Joanna A, RIDLEY, Barbara

“…Dose stabilization of intrathecal baclofen (ITB) is usually achieved within 6 to 18 months. In some patients, an increase in ITB dose may result in paradoxical…”
Get full text

Upper airway obstruction after transesophageal echocardiography by Saphir, J R, Cooper, J A, Kerbavez, R J, Larson, S F, Schiller, N B

“…Although transesophageal echocardiography is considered a generally safe procedure, occasional complications have been reported. Serious esophageal trauma and…”
Get more information

Interferon beta-1a for early multiple sclerosis: CHAMPS trial subgroup analyses by Beck, Roy W, Chandler, Danielle L, Cole, Stephen R, Simon, Jack H, Jacobs, Lawrence D, Kinkel, R Philip, Selhorst, John B, Rose, John W, Cooper, Joanna A, Rice, George, Murray, Thomas J, Sandrock, Alfred W

“…The objective of this work was to assess the effect of interferon beta-1a (Avonex) on the rate of development of clinically definite multiple sclerosis and…”
Get full text

Autosomal dominant motor system degeneration in a black family by Cooper, J A, Nakada, T, Knight, R T, Friedland, R P

“…Autosomal dominant motor system degeneration has been described primarily in Portuguese families from the Azorean Islands. The symptoms include various…”
Get more information